Epibiotech Co., Ltd. (XKON:446440)
South Korea
· Delayed Price · Currency is KRW
14,450
0.00 (0.00%)
At close: Mar 9, 2026
Epibiotech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Debt / Equity Ratio | 0.42 | 0.42 | 0.28 |
| Net Debt / Equity Ratio | -0.13 | -0.13 | -0.45 |
| Net Debt / EBITDA Ratio | 0.20 | 0.20 | 1.54 |
| Net Debt / FCF Ratio | 0.17 | 0.17 | 0.96 |
| Asset Turnover | 0.04 | 0.04 | - |
| Inventory Turnover | 14.21 | 14.21 | - |
| Quick Ratio | 1.29 | 1.29 | 3.37 |
| Current Ratio | 1.37 | 1.37 | 3.80 |
| Return on Equity (ROE) | -62.73% | -62.73% | - |
| Return on Assets (ROA) | -28.39% | -28.39% | - |
| Return on Capital Employed (ROCE) | -76.70% | -76.70% | -30.10% |
| Buyback Yield / Dilution | - | -0.60% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.